3D-QSAR studies on quinazoline antifolate thymidylate synthase inhibitors by CoMFA and CoMSIA models

Eur J Med Chem. 2010 Apr;45(4):1560-71. doi: 10.1016/j.ejmech.2009.12.065. Epub 2010 Jan 13.


Thymidylate synthase (TS) is a crucial enzyme for DNA biosynthesis and many nonclassical lipophilic antifolates targeting this enzyme are quite efficient and encouraging as antitumor drugs. Herein, we report some 3D-QSAR analyses using CoMFA and CoMSIA on quinozoline antifolates in order to have a better understanding of the mechanism of action and structure-activity relationship of these compounds. By applying leave-one-out (LOO) cross-validation study, we obtained cross-validated q(2) value of 0.573 for CoMFA and 0.445 for CoMSIA, while the non-cross-validated r(2) values for them were found to be 0.935 and 0.893, respectively. The models were graphically interpreted using CoMFA and CoMSIA contour plots. The results obtained from this study could be used for rational design of potent inhibitors against thymidylate synthase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Folic Acid Antagonists / chemistry
  • Folic Acid Antagonists / pharmacology*
  • Models, Molecular*
  • Quantitative Structure-Activity Relationship
  • Quinazolines / chemistry
  • Quinazolines / pharmacology*
  • Thymidylate Synthase / antagonists & inhibitors*


  • Folic Acid Antagonists
  • Quinazolines
  • Thymidylate Synthase